These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14165504)

  • 21. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Titration and subunit localization of active center cysteine in fibrinoligase (thrombin-activated fibrin stabilizing fector).
    Curtis CG; Stenberg P; Chou CH; Gray A; Brown KL; Lorand L
    Biochem Biophys Res Commun; 1973 May; 52(1):51-6. PubMed ID: 4736472
    [No Abstract]   [Full Text] [Related]  

  • 23. [Method for determination of the activity of the fibrin stabilizing factor].
    Khodorova EL; Smekhova EA; Svechnikova TA
    Ukr Biokhim Zh; 1970; 42(5):665-7. PubMed ID: 5511485
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of proteolytic enzymes on fibrin stabilizing factor.
    Kopeć M; Latallo ZS; Stahl M; Wegrzynowicz Z
    Biochim Biophys Acta; 1969 Jul; 181(2):437-45. PubMed ID: 4239917
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.
    Curtis CG; Brown KL; Credo RB; Domanik RA; Gray A; Stenberg P; Lorand L
    Biochemistry; 1974 Aug; 13(18):3774-80. PubMed ID: 4859234
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coagulation physiology research in a new coagulation disorder. Deficiency of a fibrin-stabilizing factor].
    DUCKERT F; JUNG E; SHMERLING DH
    Schweiz Med Wochenschr; 1961 Sep; 91():1139-40. PubMed ID: 13888166
    [No Abstract]   [Full Text] [Related]  

  • 32. PEPTIDES ATTACHED TO THROMBIN: THEIR INFLUENCE ON PROTEOLYSIS.
    LANDABURU RH; ABDALA O; MORRONE J
    Science; 1965 Apr; 148(3668):380-1. PubMed ID: 14261532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
    Lorand L; Urayama T; De Kiewiet JW; Nossel HL
    J Clin Invest; 1969 Jun; 48(6):1054-64. PubMed ID: 4977030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheology of fibrin clots. IV. Darcy constants and fiber thickness.
    Rosser RW; Roberts WW; Ferry JD
    Biophys Chem; 1977 Sep; 7(2):153-7. PubMed ID: 20173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 37. Herparin and the stabilization of fibrin.
    Cuddigan BJ
    Nature; 1968 Feb; 217(5130):779-80. PubMed ID: 4966686
    [No Abstract]   [Full Text] [Related]  

  • 38. The possibility of proteolytic activation of the fibrin-stabilizing factor.
    Buluk K; Zuch A
    Biochim Biophys Acta; 1967 Dec; 147(3):593-4. PubMed ID: 5625411
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor XIII (FSF - fibrin stabilizing factor) in pathological states with thrombin generation.
    Kloczko J; Zuch A; Bielawiec M; Buluk K
    Haematologica; 1980 Oct; 65(5):629-35. PubMed ID: 6780420
    [No Abstract]   [Full Text] [Related]  

  • 40. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.